These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7535452)

  • 41. Mobilization of peripheral blood progenitor cells using 16 versus 10 mg/kg/d G-CSF in children with malignancies.
    Kurekci AE; Kiss JE; Koehler M
    Pediatr Transplant; 1998 May; 2(2):160-4. PubMed ID: 10082450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
    Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peripheral blood progenitor cell transplantation: a single centre experience comparing two mobilisation regimens in 67 patients.
    Mahendra P; Johnson D; Scott MA; Jestice HK; Hood IM; Ager S; Bass G; Barker P; Boraks PA; Bloxham DM; Baglin TP; Marcus RE
    Bone Marrow Transplant; 1996 Apr; 17(4):503-7. PubMed ID: 8722346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization.
    Kopf B; De Giorgi U; Vertogen B; Monti G; Molinari A; Turci D; Dazzi C; Leoni M; Tienghi A; Cariello A; Argnani M; Frassineti L; Scarpi E; Rosti G; Marangolo M
    Bone Marrow Transplant; 2006 Sep; 38(6):407-12. PubMed ID: 16951690
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral blood progenitor cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia.
    Löwenberg B; van Putten WL; Ferrant A; Ossenkoppele G; Vellenga E; Verdonck LF; Gratwohl A; Boogaerts MA
    Stem Cells; 1997; 15 Suppl 1():177-80; discussion 181. PubMed ID: 9368339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delayed introduction of G-CSF after chemotherapy does not affect peripheral blood stem cell yield and engraftment kinetics in children with high-risk malignancies: retrospective study of 45 cases.
    Dolgopolov I; Andreeva L; Yankelevich M; Mscheidze D; Siegel S; Mentkevich G
    Am J Hematol; 2003 Aug; 73(4):225-9. PubMed ID: 12879423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of granulocyte-macrophage colony-stimulating factor-stimulated progenitor cells in oncology.
    Rosenfeld CS; Nemunaitis J
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):19-26. PubMed ID: 1362822
    [No Abstract]   [Full Text] [Related]  

  • 49. Peripheral blood stem cell collection and transplantation in paediatric malignancies: a monocentric experience.
    Petris MG; De Silvestro G; Cesaro S; Messina C; Marson P; Destro R; Gazzola MV; Masiero L; Carli M; Varotto S; Calore E; Scarzello G; Zanesco L
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S13-5. PubMed ID: 9989882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ex vivo manipulations of CD34+ peripheral blood progenitor cells.
    Brugger W; Scheding S; Vogel W; Bock T; Bühring HJ; Ziegler B; Kanz L
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S5-7. PubMed ID: 8899158
    [No Abstract]   [Full Text] [Related]  

  • 51. Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.
    Alici E; Björkstrand B; Treschow A; Aints A; Smith CI; Gahrton G; Dilber MS
    Cancer Gene Ther; 2007 Mar; 14(3):227-32. PubMed ID: 17082794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peripheral blood stem cell acquisition by large-volume leukapheresis in growth factor-stimulated and unstimulated rhesus monkeys: development of an animal model.
    Hillyer CD; Swenson RB; Hart KK; Lackey DA; Winton EF
    Exp Hematol; 1993 Oct; 21(11):1455-9. PubMed ID: 8405225
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Graft clonogenicity and intensity of pre-treatment: factors affecting outcome of autologous peripheral hematopoietic cell transplantation in patients with acute myeloid leukemia in first remission.
    Strodtbeck D; Bornhäuser M; Hänel M; Lerche L; Schaich M; Illmer T; Thiede C; Geissler G; Herbst R; Ehninger G; Platzbecker U
    Bone Marrow Transplant; 2005 Dec; 36(12):1083-8. PubMed ID: 16247435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation.
    Singhal S; Powles R; Kulkarni S; Treleaven J; Sirohi B; Millar B; Shepherd V; Saso R; Rowland A; Long S; Cabral S; Horton C; Mehta J
    Bone Marrow Transplant; 2000 Mar; 25(5):501-5. PubMed ID: 10713626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant.
    Hogge DE; Lambie K; Sutherland HJ; Benny WB; Dalal B; Currie C; Barnett MJ; Eaves AC; Eaves CJ
    Bone Marrow Transplant; 2000 Mar; 25(6):589-98. PubMed ID: 10734292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allogeneic haemopoietic cell transplants in Australia, 1996--a multi-centre retrospective comparison of the use of peripheral blood stem cells with bone marrow.
    Nivison-Smith I; Bradstock KF; Szer J; Durrant S; Dodds A; Hermann R; Schwarer AP; Gibson J; To LB; Arthur C;
    Bone Marrow Transplant; 2001 Jul; 28(1):21-7. PubMed ID: 11498740
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is CD33 a differentiation marker?
    Fritsch G; Buchinger P; Printz D; Dworzak MD; Strunk S; Agis H; Sliutz G; Wilfing A; Schulz U; Gadner H
    Prog Clin Biol Res; 1994; 389():377-82. PubMed ID: 7535445
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical use of hematopoietic growth factors].
    Robak T
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):365-8. PubMed ID: 1279638
    [No Abstract]   [Full Text] [Related]  

  • 60. CD34 analysis in erythropoietin mobilized peripheral blood stem cells.
    O'Kane-Murphy B; Jackson JD; Kuszynski C; Costas P; Wang PN; Warkentin PI; Kessinger A
    Prog Clin Biol Res; 1994; 389():371-6. PubMed ID: 7535444
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.